Roddie C, Dias J, O'Reilly MA, Abbasian M, et al. Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol 2021 Aug 31:JCO2100917. doi: 10.1200/JCO.21.00917.
PMID: 34464155